On 12 Nov 2026 Cigna closed at $296.27, +9.5% this year; market cap $78.15bn, P/E 13.1.
Health Care · Health Care Services · NYSE · United States
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
| Market cap | $78.15bn |
| P/E (trailing) | 13.1 |
| EPS (TTM) | $22.71 |
| Beta | 0.25 |
| Dividend | $6.24 |
| Dividend yield | 2.11% |
| Ex-dividend date | 3 Dec 2026 |
| Latest report | 5 Nov 2026 |
| Next earnings | 4 Feb 2027 |
| YTD | +9.5% |
| 1Y | +12.0% |
| 3Y | +2.2% |
| 5Y | +8.3% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $274.95bn | $5.96bn | $8.39bn |
| 2024 | $247.12bn | $3.43bn | $8.96bn |
| 2023 | $195.26bn | $5.16bn | $10.24bn |
| 2022 | $180.52bn | $6.70bn | $7.36bn |
| 2021 | $174.07bn | $5.37bn | $6.04bn |
We publish no single base value for Cigna. Our valuation methods put it between $288.01 and $801.03 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.